Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

6-(3-(4-cyano-3-trifluoromethylphenyl)-5,5-dimethyl-4-oxo-2-thioxoimidazolidin-1-yl)pyridine-2-sulfonic acid amide MeSH Supplementary Concept Data 2025

Details
Concepts

MeSH Supplementary: 6-(3-(4-cyano-3-trifluoromethylphenyl)-5,5-dimethyl-4-oxo-2-thioxoimidazolidin-1-yl)pyridine-2-sulfonic acid amide
Unique ID: C556284
RDF Unique Identifier: http://id.nlm.nih.gov/mesh/C556284
Entry Term(s): CH 5137291; CH-5137291; CH5137291
Registry Numbers: 0
Heading Mapped to: *Sulfonamides; *Thiohydantoins
Frequency: 3
Note: an androgen receptor antagonist and antineoplastic agent; structure in first source
Source: Bioorg Med Chem 2010 Dec 1;18(23):8150-7
Indexing Information: Receptors, Androgen
Date of Entry: 2011/03/06
Revision Date: 2011/03/06

6-(3-(4-cyano-3-trifluoromethylphenyl)-5,5-dimethyl-4-oxo-2-thioxoimidazolidin-1-yl)pyridine-2-sulfonic acid amide Preferred

CH 5137291 Narrower

page delivered in 0.005s